Increasing incidence of herpes zoster among Veterans
- PMID: 20178416
- DOI: 10.1086/651078
Increasing incidence of herpes zoster among Veterans
Abstract
Background: The incidence of herpes zoster in the United States has been estimated to be > or =1 million cases annually, with a higher rate in adults older than 60 years. The morbidity of the disease, including postherpetic neuralgia, imposes significant effects on quality of life. We analyzed reports of herpes zoster in the Veterans Affairs (VA) population because these patients are older and could provide a reflection of disease trends in the aging US population. These data will provide a baseline for future analyses of the incidence of herpes zoster after the introduction of the herpes zoster vaccine in late 2007.
Methods: To evaluate the trend in the annual incidence of herpes zoster for fiscal year 2000 (beginning October 1999) through fiscal year 2007 (through September 2007), we derived incidence rates using the Veterans Health Administration Decision Support System reports of herpes zoster by International Classification of Diseases, Ninth Revision codes from 2000 through 2007 and the corresponding denominator data for all veterans in care. These rates were validated by review of medical records of patients with diagnoses of herpes zoster at the Atlanta VA Medical Center.
Results: The annual incidence of herpes zoster increased from 3.10 episodes per 1000 veterans in 2000 to 5.22 in 2007 (R(2)=0.9743; P<.001). This increasing rate was seen in both men and women but only in groups older than 40 years.
Conclusion: The increasing incidence of herpes zoster in our veteran population and its effect on the quality of life of the veterans validate the need for improved rates of vaccination in this population.
Similar articles
-
Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.Ann Intern Med. 2006 Sep 5;145(5):317-25. doi: 10.7326/0003-4819-145-5-200609050-00004. Ann Intern Med. 2006. PMID: 16954357
-
Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States.Infect Control Hosp Epidemiol. 2008 Dec;29(12):1157-63. doi: 10.1086/591975. Infect Control Hosp Epidemiol. 2008. PMID: 18999945
-
Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study.Lancet Public Health. 2018 Feb;3(2):e82-e90. doi: 10.1016/S2468-2667(17)30234-7. Epub 2017 Dec 22. Lancet Public Health. 2018. PMID: 29276017 Free PMC article.
-
Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults.Drugs Aging. 2010 Feb 1;27(2):159-76. doi: 10.2165/10489140-000000000-00000. Drugs Aging. 2010. PMID: 20104941 Review.
-
A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.J Drugs Dermatol. 2006 Oct;5(9):863-6. J Drugs Dermatol. 2006. PMID: 17039651 Review.
Cited by
-
Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians.Clin Vaccine Immunol. 2014 Mar;21(3):417-26. doi: 10.1128/CVI.00818-13. Epub 2014 Jan 15. Clin Vaccine Immunol. 2014. PMID: 24429070 Free PMC article.
-
An Evidence Map of the Women Veterans' Health Research Literature (2008-2015).J Gen Intern Med. 2017 Dec;32(12):1359-1376. doi: 10.1007/s11606-017-4152-5. Epub 2017 Sep 14. J Gen Intern Med. 2017. PMID: 28913683 Free PMC article. Review.
-
Trends in herpes zoster epidemiology in Germany based on primary care sentinel surveillance data, 2005-2016.Hum Vaccin Immunother. 2018 Jul 3;14(7):1807-1814. doi: 10.1080/21645515.2018.1446718. Epub 2018 Mar 26. Hum Vaccin Immunother. 2018. PMID: 29498894 Free PMC article.
-
Herpes Zoster and Herpes Zoster Vaccine Rates Among Adults Living With and Without HIV in the Veterans Aging Cohort Study.J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):527-533. doi: 10.1097/QAI.0000000000001846. J Acquir Immune Defic Syndr. 2018. PMID: 30179984 Free PMC article.
-
Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain).Hum Vaccin Immunother. 2014;10(6):1650-60. doi: 10.4161/hv.28620. Epub 2014 May 7. Hum Vaccin Immunother. 2014. PMID: 24805130 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical